Searchable abstracts of presentations at key conferences in endocrinology

ea0050pl2 | Clinical Endocrinology Trust Lecture | SFEBES2017

Mechanisms underpinning human insulin resistance

Savage David

Adipose inflammation is increasingly percieved to be a major factor in the pathogenesis of obesity associated insulin resistance. However, human evidence supporting this hypothesis remains largely unconvincing. An alternative model is suggested by observations made in patients with rare forms of lipodystrophy; namely that a relative inability to cope with sustained surplus energy intake underpins insulin resistaance. Recent data suggesting that subtle forms of lipodystrophy ar...

ea0050pl2 | Clinical Endocrinology Trust Lecture | SFEBES2017

Mechanisms underpinning human insulin resistance

Savage David

Adipose inflammation is increasingly percieved to be a major factor in the pathogenesis of obesity associated insulin resistance. However, human evidence supporting this hypothesis remains largely unconvincing. An alternative model is suggested by observations made in patients with rare forms of lipodystrophy; namely that a relative inability to cope with sustained surplus energy intake underpins insulin resistaance. Recent data suggesting that subtle forms of lipodystrophy ar...

ea0019s80 | (1) | SFEBES2009

Magnetic resonance spectroscopy: a window into carbohydrate and lipid metabolism

Savage David

Although abnormal glucose metabolism defines type 2 diabetes mellitus (T2DM), efforts to understand the pathogenesis of T2DM are increasingly focused on disordered lipid metabolism. Magnetic resonance spectroscopy (MRS) is a non-invasive technique which provides real time data. Its uses in metabolic studies include: 1) static measurements of energy stores e.g. intramyocellular and hepatic glycogen and triglyceride levels and, 2) dynamic measures of mitochondrial function (ATP ...

ea0056s20.1 | All you need to know about lipodystrophy (Endorsed by Endocrine Connections) | ECE2018

Lipodystrophy as a model for prevalent insulin resistance

Savage David

All forms of severe lipodystrophy are associated with features of the metabolic syndrome including insulin resistance, T2DM, NAFLD, dyslipidaemia and cardiovascular disease. The question I will address is if this means that what happens in patients with monogenic forms of lipodystrophy is at all relevant to common forms of insulin resistance and the metabolic syndrome....

ea0061p004 | (1) | OU2019

Evidence of aberrant inflammation in patients with Lipodystrophy

Sajid Sehar , Burke Bernard , Mee Christopher , Savage David , Renshaw Derek

Introduction: Lipodystrophy is a rare medical condition with a varied etiology that is characterised by a complete or partial loss of adipose tissue, which can be generalised, partial or localised. Patients have altered secretion of adipokines, such as, Leptin and Adiponectin. Ectopic lipid accumulation is common and leads to metabolic complications associated with insulin resistance (IR) such as, diabetes mellitus (DM) and hypertriglyceridemia. Levels of circulating inflammat...

ea0044p180 | Obesity and Metabolism | SFEBES2016

Metabolic surgery with Roux-en-y Gastric bypass is an effective treatment in patients with Familial Partial Lipodystrophy and Body Mass Index Less than 35 kg/m2

Adams Claire , Savage David , Gaff Lisa , Flanagan Catherine , Jenkins-Liu Charlotte , Semple Robert , Withers Elaine , O'Rahilly Stephen , Stears Anna

Introduction: Familial Partial Lipodystrophy Type 1 (FPLD1) is characterised by loss of gluteal and limb subcutaneous fat and increased abdominal fat. The genetic basis is currently unknown. FPLD1 is frequently associated with metabolic problems including diabetes, insulin resistance, dyslipidaemia and non-alcoholic fatty liver disease. Despite central adiposity and severe metabolic abnormalities, this group of patients often do not qualify for NHS funding for bariatric surger...

ea0031p225 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Non-alcoholic fatty liver disease in patients attending the National Severe Insulin Resistance Service

Leiter Sarah M , Sleigh Alison , Adams Claire , Harris Julie , Lomas David J , Allison Michael , Semple Robert , Savage David , Stears Anna

Introduction: The prevalence of non-alcoholic fatty liver disease (NAFLD) is greatly increased in patients with lipodystrophy and some other forms of severe insulin resistance. Liver biopsy remains the definitive technique for diagnosis and staging of NAFLD. However, non-invasive techniques, such as magnetic resonance spectroscopy (MRS) and magnetic resonance imaging (MRI) are increasingly used to assess response to therapeutic interventions. The National Severe Insulin Resist...

ea0065p236 | Metabolism and Obesity | SFEBES2019

Case reports of immunosuppression therapy for anti-insulin receptor and anti-insulin antibodies in patients attending the national severe insulin resistance service

Liu Charlotte Jenkins , Adams Claire , Church David , Flanagan Catherine , Gaff Lisa , Jayne David , Melvin Audrey , O'Rahilly Stephen , Pizirtzidou Eirini , Savage David , Semple Robert , Withers Elaine , Stears Anna

Introduction: Immune mediated cases of severe insulin resistant diabetes are very rare. We report responses to immunosuppression with rituximab in two patients.Case 1: A 31 year old black African female, BMI 22.84 kg/m², was referred with new onset diabetes, diagnosed shortly following a miscarriage. She had weight loss, acanthosis nigricans, nocturnal hypoglycaemia and severe hyperandrogenism . She was on an insulin pump and required >1000 units in...

ea0063p586 | Diabetes, Obesity and Metabolism 2 | ECE2019

Real-world experience of generalized and partial lipodystrophy patients enrolled in the metreleptin early access program

Cook Keziah , Stears Anna , Araujo-Vilar David , Santini Ferruccio , O'Rahilly Stephen , Ceccarini Giovanni , Tibrewala Shruti , Bradt Pamela , Vigouroux Corinne , Vatier Camille , Savage David B

Objective: To evaluate the real-world experience of patients with generalized (GL) and partial (PL) lipodystrophy initiating treatment with metreleptin as part of an early access program (EAP).Methods: A retrospective data collection was conducted from four countries for patients enrolled in the EAP. A descriptive analysis was performed on selected patient characteristics, baseline organ impairments and complications, and response to metreleptin therapy,...

ea0059p154 | Obesity & metabolism | SFEBES2018

Dominant-negative mutations in PPAR alpha are present in unselected human populations and have a metabolic signature

Melvin Audrey , Lam Brian , Langenberg Claudia , Agostini Maura , Schoenmakers Erik , Luan Jian'an , Rainbow Kara , Yeo Giles S , Wareham Nick , Savage David B , Chatterjee Krishna , O'Rahilly Stephen

The study of humans carrying dominant negative mutations in PPAR gamma has contributed significantly to our understanding of its role in human physiology. To date, comparable studies of PPAR alpha have not been reported. Using a pooled approach, we undertook exon sequencing of PPARA in 11,848 adult participants of the Fenland study, a population-based cohort study with detailed metabolic phenotyping. Twenty-nine PPARA missense variants were detected (allelic ...